p 2012

Treatment of pulmonary embolism of 260 in-patients of acute medical department in the elderly

WEBEROVÁ, Dana, Pavel WEBER, Hana MATĚJOVSKÁ KUBEŠOVÁ and Hana MELUZÍNOVÁ

Basic information

Original name

Treatment of pulmonary embolism of 260 in-patients of acute medical department in the elderly

Authors

WEBEROVÁ, Dana (203 Czech Republic, guarantor, belonging to the institution), Pavel WEBER (203 Czech Republic, belonging to the institution), Hana MATĚJOVSKÁ KUBEŠOVÁ (203 Czech Republic) and Hana MELUZÍNOVÁ (203 Czech Republic, belonging to the institution)

Edition

Congress of the Clinical Section IAGG-ER, 2012

Other information

Language

English

Type of outcome

Vyžádané přednášky

Field of Study

30200 3.2 Clinical medicine

Country of publisher

Czech Republic

Confidentiality degree

není předmětem státního či obchodního tajemství

RIV identification code

RIV/00216224:14110/12:00063465

Organization unit

Faculty of Medicine

Keywords (in Czech)

pozdní stáří - plicní embolizace - hluboká žilní trombóza - diagnostika - terapie - rizikové faktory - antikoagulační terapie

Keywords in English

Advanced age – pulmonary embolism (PE) – deep venous thrombosis (DVT) – diagnostics – therapy – risk factors – anticoagulant therapy

Tags

International impact, Reviewed
Změněno: 27/4/2014 09:40, MUDr. Dana Weberová

Abstract

V originále

The retrospective analysis of the database of inpatients with the target assess the clinical course of PE according to prevalence, mortality, average duration of stay, risk factors, used diagnostic methods and kinds of therapy. Another aim of the study was a comparison of the dates among the survivors and deceased persons. We found the most important risk factors in the group of the deceased immobility (p<0.001)` heart failure (p<0.005) and stroke (p<0.01). On the contrary in the survivor group there were more frequent risk factors obesity (p<0.025); deep venous thrombosis (p<0.025) and tumors (p<0.05). Previous operations and traumas in the last month did not show any significant difference between both groups. Used treatment methods were evaluated, too. In the group of those who died predominated multi-morbidity, often frailty and geriatric giants even if the anticoagulant therapy was used comparably in both groups (survivors and the deceased).
Displayed: 11/11/2024 00:26